Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Covre

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNALuca Sigalotti, Alessia Covre, Francesca Colizzi, et al.
Current Oncology Reports|October 22, 2021
COVID and Lung CancerLuana Calabrò, Giulia Rossi, Alessia Covre, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Cancer testis antigens and melanoma stem cells: new promises for therapeutic interventionLuca Sigalotti, Alessia Covre, Hugues J M Nicolay, et al.
Cardiovascular Research|October 9, 2009
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumoursEster Fonsatti, Hugues J M Nicolay, Maresa Altomonte, et al.
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Cytokine & Growth Factor Reviews|July 25, 2017
Immunotherapy targeting immune check-point(s) in brain metastasesAnna Maria Di Giacomo, Monica Valente, Alessia Covre, et al.
Seminars in Oncology|May 13, 2015
Epigenetics meets immune checkpointsAlessia Covre, Sandra Coral, Anna Maria Di Giacomo, et al.
Pharmacology & Therapeutics|February 17, 2024
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?Elena Splendiani, Zein Mersini Besharat, Alessia Covre, et al.
Cancer Research|March 17, 2007
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man storySandra Coral, Luca Sigalotti, Alessia Covre, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 24, 2021
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundationMichele Maio, Michael Lahn, Anna Maria Di Giacomo, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNALuca Sigalotti, Alessia Covre, Francesca Colizzi, et al.
Current Oncology Reports|October 22, 2021
COVID and Lung CancerLuana Calabrò, Giulia Rossi, Alessia Covre, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Cancer testis antigens and melanoma stem cells: new promises for therapeutic interventionLuca Sigalotti, Alessia Covre, Hugues J M Nicolay, et al.
Cardiovascular Research|October 9, 2009
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumoursEster Fonsatti, Hugues J M Nicolay, Maresa Altomonte, et al.
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Cytokine & Growth Factor Reviews|July 25, 2017
Immunotherapy targeting immune check-point(s) in brain metastasesAnna Maria Di Giacomo, Monica Valente, Alessia Covre, et al.
Seminars in Oncology|May 13, 2015
Epigenetics meets immune checkpointsAlessia Covre, Sandra Coral, Anna Maria Di Giacomo, et al.
Pharmacology & Therapeutics|February 17, 2024
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?Elena Splendiani, Zein Mersini Besharat, Alessia Covre, et al.
Cancer Research|March 17, 2007
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man storySandra Coral, Luca Sigalotti, Alessia Covre, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 24, 2021
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundationMichele Maio, Michael Lahn, Anna Maria Di Giacomo, et al.
Pageof 6